Squaric Acid 0.1% Topical Solution (Clinic) 30 mL

FDA recall notice · announced February 5, 2020 · Mprx, Inc. Dba Medical Park Pharmacy

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Squaric Acid 0.1% Topical Solution (Clinic) 30 mL

Reason for recall

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

Notes

Distribution: TX
Lot/code information: Lot: 61380:42 Use by: 05/04/2020
Quantity: 1 bottle
Status: Terminated
Products in this recall event:
- Progesterone 200 mg Troche (D-0811-2020)
- Tadalafil 6 mg Capsule (D-0819-2020)
- Naltrexone 4.5 mg capsule (D-0810-2020)
- Lidocaine/Priloc/PE 15/5/0.25% 30 GM jars (D-0805-2020)
- Lidocaine/Priloc/PE 30/5/0.25% 30 GM jars (D-0806-2020)
- Sildenafil 80 mg capsules (D-0815-2020)
- Progesterone E4M SR 100 mg capsules (D-0813-2020)
- Testosterone Topical Cream 4% (D-0820-2020)
- Finasteride/Biotin 1 mg/50 mcg (D-0804-2020)
- Magic Bullet Supplement (D-0809-2020)
- Sildenafil 200 mg Troche (Clinic) (D-0814-2020)
- Progesterone 50 mg capsules (D-0812-2020)
- Liothyronine (T3) 92.5 MCG (D-0808-2020)
- DHEA/Pregnenol One 10.25 MG Cap (D-0803-2020)
- Tadalafil 20 mg Troche (D-0818-2020)
- T3/T4 SR 9 mcg/38 mcg capsule (D-0817-2020)
- Liothyronine (T3) 80 mcg SR cap (D-0807-2020)
- Squaric Acid 0.1% Topical Solution (Clinic) 30 mL (D-0816-2020)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.